News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
729,535 Results
Type
Article (44280)
Company Profile (312)
Press Release (684943)
Multimedia
Podcasts (75)
Webinars (13)
Section
Business (212031)
Career Advice (2098)
Deals (36421)
Drug Delivery (100)
Drug Development (82418)
Employer Resources (176)
FDA (16769)
Job Trends (15339)
News (356511)
Policy (33451)
Tag
Academia (2716)
Accelerated approval (5)
Adcomms (20)
Allergies (90)
Alliances (52519)
ALS (95)
Alzheimer's disease (1409)
Antibody-drug conjugate (ADC) (143)
Approvals (16762)
Artificial intelligence (292)
Autoimmune disease (23)
Automation (16)
Bankruptcy (365)
Best Places to Work (11936)
BIOSECURE Act (19)
Biosimilars (107)
Biotechnology (221)
Bladder cancer (80)
Brain cancer (27)
Breast cancer (294)
Cancer (2342)
Cardiovascular disease (184)
Career advice (1757)
Career pathing (31)
CAR-T (162)
Cell therapy (450)
Cervical cancer (20)
Clinical research (66955)
Collaboration (894)
Company closure (2)
Compensation (566)
Complete response letters (19)
COVID-19 (2678)
CRISPR (47)
C-suite (260)
Cystic fibrosis (105)
Data (2327)
Decentralized trials (2)
Denatured (31)
Depression (45)
Diabetes (277)
Diagnostics (6651)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (44)
Drug discovery (124)
Drug pricing (106)
Drug shortages (27)
Duchenne muscular dystrophy (97)
Earnings (88689)
Editorial (39)
Employer branding (22)
Employer resources (151)
Events (117491)
Executive appointments (763)
FDA (18161)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (798)
Gene editing (119)
Generative AI (26)
Gene therapy (325)
GLP-1 (736)
Government (4537)
Grass and pollen (5)
Guidances (150)
Healthcare (19557)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (123)
Indications (30)
Infectious disease (2826)
Inflammatory bowel disease (147)
Inflation Reduction Act (8)
Influenza (54)
Intellectual property (101)
Interviews (324)
IPO (16872)
IRA (41)
Job creations (3827)
Job search strategy (1494)
Kidney cancer (11)
Labor market (43)
Layoffs (489)
Leadership (18)
Legal (8137)
Liver cancer (78)
Lung cancer (328)
Lymphoma (158)
Machine learning (9)
Management (62)
Manufacturing (330)
MASH (74)
Medical device (14126)
Medtech (14131)
Mergers & acquisitions (20128)
Metabolic disorders (712)
Multiple sclerosis (82)
NASH (16)
Neurodegenerative disease (93)
Neuropsychiatric disorders (27)
Neuroscience (1963)
NextGen: Class of 2025 (6845)
Non-profit (4625)
Now hiring (40)
Obesity (374)
Opinion (218)
Ovarian cancer (80)
Pain (93)
Pancreatic cancer (89)
Parkinson's disease (152)
Partnered (22)
Patents (251)
Patient recruitment (117)
Peanut (49)
People (59612)
Pharmaceutical (69)
Pharmacy benefit managers (19)
Phase I (21010)
Phase II (29467)
Phase III (21852)
Pipeline (1353)
Policy (148)
Postmarket research (2591)
Preclinical (9037)
Press Release (71)
Prostate cancer (107)
Psychedelics (30)
Radiopharmaceuticals (265)
Rare diseases (389)
Real estate (6236)
Recruiting (65)
Regulatory (22921)
Reports (47)
Research institute (2463)
Resumes & cover letters (361)
Rett syndrome (5)
RNA editing (5)
RSV (43)
Schizophrenia (72)
Series A (138)
Series B (89)
Service/supplier (15)
Sickle cell disease (54)
Special edition (16)
Spinal muscular atrophy (148)
Sponsored (30)
Startups (3846)
State (2)
Stomach cancer (13)
Supply chain (69)
Tariffs (48)
The Weekly (42)
Vaccines (730)
Venture capitalists (43)
Weight loss (242)
Women's health (37)
Worklife (16)
Date
Last 7 days (951)
Last 30 days (3064)
Last 365 days (33220)
2025 (11973)
2024 (36237)
2023 (41156)
2022 (52411)
2021 (57002)
2020 (55635)
2019 (48441)
2018 (36462)
2017 (33581)
2016 (33185)
2015 (39396)
2014 (33008)
2013 (28068)
2012 (30320)
2011 (30910)
2010 (28909)
Location
Africa (759)
Alabama (55)
Alaska (7)
Arizona (243)
Arkansas (14)
Asia (40631)
Australia (6765)
California (6501)
Canada (2077)
China (547)
Colorado (278)
Connecticut (289)
Delaware (163)
Europe (88960)
Florida (955)
Georgia (222)
Idaho (60)
Illinois (569)
India (26)
Indiana (326)
Iowa (11)
Japan (174)
Kansas (109)
Kentucky (25)
Louisiana (12)
Maine (62)
Maryland (931)
Massachusetts (4881)
Michigan (245)
Minnesota (412)
Mississippi (2)
Missouri (88)
Montana (30)
Nebraska (25)
Nevada (68)
New Hampshire (69)
New Jersey (1817)
New Mexico (28)
New York (1828)
North Carolina (1034)
North Dakota (9)
Northern California (2841)
Ohio (213)
Oklahoma (15)
Oregon (37)
Pennsylvania (1436)
Puerto Rico (14)
Rhode Island (34)
South America (1155)
South Carolina (25)
South Dakota (1)
Southern California (2445)
Tennessee (107)
Texas (960)
United States (24475)
Utah (195)
Virginia (155)
Washington D.C. (65)
Washington State (581)
West Virginia (3)
Wisconsin (59)
729,535 Results for "bluegrass vascular technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Hemostemix and FireFly Neuroscience’s Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01
A growing body of clinical evidence supports the use of Firefly’s FDA-Cleared BNA(TM) platform to study ACP-01 as a treatment for vascular dementia
March 6, 2025
·
10 min read
Press Releases
Piccolo Medical, Inc. Announces Distribution Agreement with Spectrum Vascular
January 13, 2025
·
2 min read
Press Releases
Stryker completes acquisition of Inari Medical, Inc., providing entry into the high-growth peripheral vascular segment
February 19, 2025
·
3 min read
Press Releases
Spectrum Vascular Welcomes New Executive Leadership
April 14, 2025
·
4 min read
Press Releases
Access Vascular Catheters with MIMIX® Technology Added to Recon Supply’s Federal Supply Schedule Contract
February 12, 2025
·
3 min read
Press Releases
Vivasure Medical Receives CE Mark Approval in Europe for PerQseal Elite Vascular Closure System
April 22, 2025
·
2 min read
Press Releases
CORRECTING and REPLACING Access Vascular Highlights New Midline Catheter Data at AVA 2024
Data Presented at the AVA Annual Scientific Meeting Shows Significantly Lower Complication and Failure Rates with Access Vascular’s HydroMID® Midline Catheter
October 2, 2024
·
2 min read
Press Releases
Ashvattha Therapeutics to Present Positive Phase 2 Results for Subcutaneous Migaldendranib in Retinal Vascular Disease at ARVO
May 8, 2025
·
3 min read
Press Releases
Vasorum Announces FDA Approval of its Celt ACD® PLUS Vascular Closure Device
March 28, 2025
·
3 min read
Press Releases
Stryker announces definitive agreement to acquire Inari Medical, Inc., providing entry into high-growth peripheral vascular segment
January 7, 2025
·
9 min read
1 of 72,954
Next
